Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Analysis of Cricket Ball Type and Innings on State Level Cricket Batter's Performance.

Connor JD, Sinclair WH, Leicht AS, Doma K.

Front Psychol. 2019 Oct 24;10:2347. doi: 10.3389/fpsyg.2019.02347. eCollection 2019.

2.

Performance Differences of Temporal Parameters and Point Outcome between Elite Men's and Women's Badminton Players According to Match-Related Contexts.

Gomez MÁ, Rivas F, Connor JD, Leicht AS.

Int J Environ Res Public Health. 2019 Oct 23;16(21). pii: E4057. doi: 10.3390/ijerph16214057.

3.

Moderating factors influence the relative age effect in Australian cricket.

Connor JD, Renshaw I, Doma K.

PeerJ. 2019 May 17;7:e6867. doi: 10.7717/peerj.6867. eCollection 2019.

4.

Emergence of Skilled Behaviors in Professional, Amateur and Junior Cricket Batsmen During a Representative Training Scenario.

Connor JD, Farrow D, Renshaw I.

Front Psychol. 2018 Oct 30;9:2012. doi: 10.3389/fpsyg.2018.02012. eCollection 2018.

5.

China's response to a national land-system sustainability emergency.

Bryan BA, Gao L, Ye Y, Sun X, Connor JD, Crossman ND, Stafford-Smith M, Wu J, He C, Yu D, Liu Z, Li A, Huang Q, Ren H, Deng X, Zheng H, Niu J, Han G, Hou X.

Nature. 2018 Jul;559(7713):193-204. doi: 10.1038/s41586-018-0280-2. Epub 2018 Jul 11.

PMID:
29995865
6.

Climate change and the economics of biomass energy feedstocks in semi-arid agricultural landscapes: A spatially explicit real options analysis.

Regan CM, Connor JD, Raja Segaran R, Meyer WS, Bryan BA, Ostendorf B.

J Environ Manage. 2017 May 1;192:171-183. doi: 10.1016/j.jenvman.2017.01.049. Epub 2017 Feb 2.

PMID:
28160645
7.

Effect of Different Evasion Maneuvers on Anticipation and Visual Behavior in Elite Rugby League Players.

Connor JD, Crowther RG, Sinclair WH.

Motor Control. 2018 Jan 1;22(1):18-27. doi: 10.1123/mc.2016-0034. Epub 2017 Sep 5.

PMID:
28121283
8.

Real options analysis for land use management: Methods, application, and implications for policy.

Regan CM, Bryan BA, Connor JD, Meyer WS, Ostendorf B, Zhu Z, Bao C.

J Environ Manage. 2015 Sep 15;161:144-152. doi: 10.1016/j.jenvman.2015.07.004. Epub 2015 Jul 10. Review.

PMID:
26164637
9.

Land use efficiency: anticipating future demand for land-sector greenhouse gas emissions abatement and managing trade-offs with agriculture, water, and biodiversity.

Bryan BA, Crossman ND, Nolan M, Li J, Navarro J, Connor JD.

Glob Chang Biol. 2015 Nov;21(11):4098-114. doi: 10.1111/gcb.13020. Epub 2015 Sep 23.

PMID:
26147156
10.

The use of spatial manipulation to examine goalkeepers' anticipation.

Woolley TL, Crowther RG, Doma K, Connor JD.

J Sports Sci. 2015;33(17):1766-74. doi: 10.1080/02640414.2015.1014830. Epub 2015 Feb 19.

PMID:
25695331
11.

Ecosystem services in urban water investment.

Kandulu JM, Connor JD, MacDonald DH.

J Environ Manage. 2014 Dec 1;145:43-53. doi: 10.1016/j.jenvman.2014.05.024. Epub 2014 Jul 1.

PMID:
24992048
12.

Ecohydrological and socioeconomic integration for the operational management of environmental flows.

Bryan BA, Higgins A, Overton IC, Holland K, Lester RE, King D, Nolan M, MacDonald DH, Connor JD, Bjornsson T, Kirby M.

Ecol Appl. 2013 Jul;23(5):999-1016.

PMID:
23967571
13.

Bioavailability and short-term tolerability of alendronate in glucocorticoid-treated children.

Nakhla M, Denker AE, Connor JD, Carpenter TO, Walson PD, Porras AG, Matthews CZ, Larson P, Freeman A, Wagner JA, Ward LM.

Clin Ther. 2011 Oct;33(10):1516-23. doi: 10.1016/j.clinthera.2011.09.001. Epub 2011 Oct 2.

PMID:
21962451
14.

Quantification of Lansoprazole in Oral Suspension by Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap Time-of-Flight Mass Spectrometry.

Brown SD, Connor JD, Smallwood NC, Lugo RA.

Int J Anal Chem. 2011;2011:832414. doi: 10.1155/2011/832414. Epub 2011 Jun 22.

15.

Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease.

Burns JC, Best BM, Mejias A, Mahony L, Fixler DE, Jafri HS, Melish ME, Jackson MA, Asmar BI, Lang DJ, Connor JD, Capparelli EV, Keen ML, Mamun K, Keenan GF, Ramilo O.

J Pediatr. 2008 Dec;153(6):833-8. doi: 10.1016/j.jpeds.2008.06.011. Epub 2008 Jul 30.

16.

Lipoproteins inhibit platelet aggregation and arachidonic acid metabolism in experimental hypercholesterolaemia.

Aslam R, Saeed SA, Ahmed S, Connor JD.

Clin Exp Pharmacol Physiol. 2008 May;35(5-6):656-62. doi: 10.1111/j.1440-1681.2007.04863.x. Epub 2008 Jan 21.

PMID:
18215184
17.

Inhibitors of phosphatidylinositide 3-kinase: effects on reactive oxygen species and platelet aggregation.

Saeed SA, Connor JD, Imran, Quadri J, Tasneem S, Ahmed S, Mesaik MA, Choudhary MI.

Pharmacol Rep. 2007 Mar-Apr;59(2):238-43.

19.

Impact of pregnancy on abacavir pharmacokinetics.

Best BM, Mirochnick M, Capparelli EV, Stek A, Burchett SK, Holland DT, Read JS, Smith E, Hu C, Spector SA, Connor JD; PACTG P1026s Study Team.

AIDS. 2006 Feb 28;20(4):553-60.

PMID:
16470119
20.

Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.

Shapiro RL, Holland DT, Capparelli E, Lockman S, Thior I, Wester C, Stevens L, Peter T, Essex M, Connor JD, Mirochnick M.

J Infect Dis. 2005 Sep 1;192(5):720-7. Epub 2005 Jul 27.

PMID:
16088821
21.

Signaling mechanisms mediated by G-protein coupled receptors in human platelets.

Saeed SA, Rasheed H, Fecto FA, Achakzai MI, Ali R, Connor JD, Gilani AU.

Acta Pharmacol Sin. 2004 Jul;25(7):887-92.

22.

Developmental pharmacokinetics and pharmacodynamics of nizatidine.

Abdel-Rahman SM, Johnson FK, Connor JD, Staiano A, Dupont C, Tolia V, Winter H, Gauthier-Dubois G, Kearns GL.

J Pediatr Gastroenterol Nutr. 2004 Apr;38(4):442-51.

PMID:
15085026
23.

Quality assurance program for clinical measurement of antiretrovirals: AIDS clinical trials group proficiency testing program for pediatric and adult pharmacology laboratories.

Holland DT, DiFrancesco R, Stone J, Hamzeh F, Connor JD, Morse GD; Adult and Pediatric AIDS Clinical Trials Group Pharmacology Laboratory Committees, Pediatric AIDS Clinical Trials Group.

Antimicrob Agents Chemother. 2004 Mar;48(3):824-31.

24.

Plasma from rheumatoid patients taking low dose methotrexate enhances platelet aggregation.

Saeed SA, Gilani AH, Rasheed H, Bhatti FN, Atiq M, Qureshi A, Jafary R, Connor JD.

Res Commun Mol Pathol Pharmacol. 2002;111(1-4):69-76.

PMID:
14632315
25.

Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children.

Capparelli EV, Englund JA, Connor JD, Spector SA, McKinney RE, Palumbo P, Baker CJ.

J Clin Pharmacol. 2003 Feb;43(2):133-40.

PMID:
12616665
26.

Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in kawasaki disease.

Best BM, Burns JC, DeVincenzo J, Phelps SJ, Blumer JL, Wilson JT, Capparelli EV, Connor JD; Pediatric Pharmacology Research Unit Network.

Curr Ther Res Clin Exp. 2003 Feb;64(2):96-115. doi: 10.1016/S0011-393X(03)00018-3.

27.

Pharmacokinetics and tolerance of zidovudine in preterm infants.

Capparelli EV, Mirochnick M, Dankner WM, Blanchard S, Mofenson L, McSherry GD, Gay H, Ciupak G, Smith B, Connor JD; Pediatric AIDS Clinical Trials Group 331 Investigators.

J Pediatr. 2003 Jan;142(1):47-52.

PMID:
12520254
28.

Comparison of effects of khat extract and amphetamine on motor behaviors in mice.

Connor JD, Rostom A, Makonnen E.

J Ethnopharmacol. 2002 Jun;81(1):65-71.

PMID:
12020929
29.

Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants.

Capparelli EV, Sullivan JL, Mofenson L, Smith E, Graham B, Britto P, Becker MI, Holland D, Connor JD, Luzuriaga K; Pediatric ACTG 356 Investigators.

Pediatr Infect Dis J. 2001 Aug;20(8):746-51.

PMID:
11734735
30.

Second messengers in platelet aggregation evoked by serotonin and A23187, a calcium ionophore.

Connor JD, Rasheed H, Gilani AH, Cheema M, Rizvi Z, Saeed SA.

Life Sci. 2001 Oct 26;69(23):2759-64.

PMID:
11720080
31.

The influences of renal function and maturation on vancomycin elimination in newborns and infants.

Capparelli EV, Lane JR, Romanowski GL, McFeely EJ, Murray W, Sousa P, Kildoo C, Connor JD.

J Clin Pharmacol. 2001 Sep;41(9):927-34.

PMID:
11549096
32.

Wortmannin inhibits platelet aggregation produced by interaction of gamma-aminobutyric acid and the calcium tonophore, A23187.

Saeed SA, Connor JD, Rasheed H, Gilani AH, Lodhi S, Ali SS, Rashid S, Khan E, Shah BH.

Res Commun Mol Pathol Pharmacol. 2001 Jul;109(1-2):87-93.

PMID:
11458988
33.

A look at the future of pediatric therapeutics: an investigator's perspective of the new pediatric rule.

Connor JD.

Pediatrics. 1999 Sep;104(3 Pt 2):610-3. No abstract available.

PMID:
10469801
34.
36.

Differentiation and characterization of enteroviruses by computer-assisted viral protein fingerprinting.

Holland DT, Senne J, Peter CR, Urmenta C, Connor JD.

J Clin Microbiol. 1998 Jun;36(6):1588-94.

37.

Simple high-performance liquid chromatography method for the simultaneous determination of serum caffeine and paraxanthine following rapid sample preparation.

Holland DT, Godfredsen KA, Page T, Connor JD.

J Chromatogr B Biomed Sci Appl. 1998 Apr 10;707(1-2):105-10.

PMID:
9613939
38.

Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease.

Gray GC, McPhate DC, Leinonen M, Cassell GH, Deperalta EP, Putnam SD, Karcher JA, Sawyer MH, Laurila A, Connor JD.

Clin Infect Dis. 1998 Jan;26(1):103-10.

PMID:
9455517
40.

Clinical and laboratory characteristics of a large cohort of symptomatic, human immunodeficiency virus-infected infants and children. AIDS Clinical Trials Group Protocol 152 Study Team.

Englund JA, Baker CJ, Raskino C, McKinney RE, Lifschitz MH, Petrie B, Fowler MG, Connor JD, Mendez H, O'Donnell K, Wara DW.

Pediatr Infect Dis J. 1996 Nov;15(11):1025-36.

PMID:
8933553
41.

A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team.

Japour AJ, Lertora JJ, Meehan PM, Erice A, Connor JD, Griffith BP, Clax PA, Holden-Wiltse J, Hussey S, Walesky M, Cooney E, Pollard R, Timpone J, McLaren C, Johanneson N, Wood K, Booth D, Bassiakos Y, Crumpacker CS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Nov 1;13(3):235-46.

PMID:
8898668
42.

Health care worker exposure to aerosolized ribavirin: biological and air monitoring.

Shults RA, Baron S, Decker J, Deitchman SD, Connor JD.

J Occup Environ Med. 1996 Mar;38(3):257-63.

PMID:
8882097
43.

Simple reversed-phase high-performance liquid chromatography quantitation of ganciclovir in human serum and urine.

Page T, Sherwood C, Connor JD, Tarnowski T.

J Chromatogr B Biomed Appl. 1996 Jan 26;675(2):342-6.

PMID:
8852725
44.

Intravenous ribavirin by constant infusion for serious influenza and parainfluenzavirus infection.

Hayden FG, Sable CA, Connor JD, Lane J.

Antivir Ther. 1996 Jan;1(1):51-6.

PMID:
11322259
45.

Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis.

Kuppermann BD, Assil KK, Vuong C, Besen G, Wiley CA, De Clercq E, Bergeron-Lynn G, Connor JD, Pursley M, Munguia D, Freeman WR.

J Infect Dis. 1996 Jan;173(1):18-23.

PMID:
8537656
46.

Population differences in ganciclovir clearance as determined by nonlinear mixed-effects modelling.

Yuen GJ, Drusano GL, Fletcher C, Capparelli E, Connor JD, Lalezari JP, Drew L, Follansbee S, Busch D, Jacobson M, et al.

Antimicrob Agents Chemother. 1995 Oct;39(10):2350-2.

47.

Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis.

Arevalo JF, Gonzalez C, Capparelli EV, Kirsch LS, Garcia RF, Quiceno JI, Connor JD, Gambertoglio J, Bergeron-Lynn G, Freeman WR.

J Infect Dis. 1995 Oct;172(4):951-6.

PMID:
7561215
48.

Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group.

Spector SA, Busch DF, Follansbee S, Squires K, Lalezari JP, Jacobson MA, Connor JD, Jung D, Shadman A, Mastre B, et al.

J Infect Dis. 1995 Jun;171(6):1431-7.

PMID:
7769276
49.

Therapy of pediatric AIDS.

Wu LR, Capparelli EV, Connor JD.

Curr Opin Pediatr. 1995 Apr;7(2):214-9. Review.

PMID:
7787939
50.

Effect of partial retinal destruction and gliosis on the intravitreal pharmacokinetics of HPMPC.

Kim JW, el-Haig W, Capparelli EV, Besen G, Connor JD, Freeman WR.

Retina. 1995;15(6):513-7.

PMID:
8747447

Supplemental Content

Loading ...
Support Center